191 related articles for article (PubMed ID: 37708950)
1. Understanding the neuronal synapse and challenges associated with the mitochondrial dysfunction in mild cognitive impairment and Alzheimer's disease.
Verma H; Gangwar P; Yadav A; Yadav B; Rao R; Kaur S; Kumar P; Dhiman M; Taglialatela G; Mantha AK
Mitochondrion; 2023 Nov; 73():19-29. PubMed ID: 37708950
[TBL] [Abstract][Full Text] [Related]
2. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
[TBL] [Abstract][Full Text] [Related]
3. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
Reddy PH; Oliver DM
Cells; 2019 May; 8(5):. PubMed ID: 31121890
[TBL] [Abstract][Full Text] [Related]
4. The Role of Mitochondrial Impairment in Alzheimer´s Disease Neurodegeneration: The Tau Connection.
Quntanilla RA; Tapia-Monsalves C
Curr Neuropharmacol; 2020; 18(11):1076-1091. PubMed ID: 32448104
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Drp1 Ameliorates Synaptic Depression, Aβ Deposition, and Cognitive Impairment in an Alzheimer's Disease Model.
Baek SH; Park SJ; Jeong JI; Kim SH; Han J; Kyung JW; Baik SH; Choi Y; Choi BY; Park JS; Bahn G; Shin JH; Jo DS; Lee JY; Jang CG; Arumugam TV; Kim J; Han JW; Koh JY; Cho DH; Jo DG
J Neurosci; 2017 May; 37(20):5099-5110. PubMed ID: 28432138
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease.
Cai Q; Tammineni P
J Alzheimers Dis; 2017; 57(4):1087-1103. PubMed ID: 27767992
[TBL] [Abstract][Full Text] [Related]
7. Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model.
Du H; Guo L; Yan S; Sosunov AA; McKhann GM; Yan SS
Proc Natl Acad Sci U S A; 2010 Oct; 107(43):18670-5. PubMed ID: 20937894
[TBL] [Abstract][Full Text] [Related]
8. Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer's disease neurons.
Calkins MJ; Reddy PH
Biochim Biophys Acta; 2011 Apr; 1812(4):507-13. PubMed ID: 21241801
[TBL] [Abstract][Full Text] [Related]
9. Gain of PITRM1 peptidase in cortical neurons affords protection of mitochondrial and synaptic function in an advanced age mouse model of Alzheimer's disease.
Du F; Yu Q; Yan S; Zhang Z; Vangavaragu JR; Chen D; Yan SF; Yan SS
Aging Cell; 2021 May; 20(5):e13368. PubMed ID: 33951271
[TBL] [Abstract][Full Text] [Related]
10. Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damage.
Manczak M; Reddy PH
Hum Mol Genet; 2012 Jun; 21(11):2538-47. PubMed ID: 22367970
[TBL] [Abstract][Full Text] [Related]
11. Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease.
Reddy PH
Brain Res; 2011 Sep; 1415():136-48. PubMed ID: 21872849
[TBL] [Abstract][Full Text] [Related]
12. Wnt Signaling Prevents the Aβ Oligomer-Induced Mitochondrial Permeability Transition Pore Opening Preserving Mitochondrial Structure in Hippocampal Neurons.
Arrázola MS; Ramos-Fernández E; Cisternas P; Ordenes D; Inestrosa NC
PLoS One; 2017; 12(1):e0168840. PubMed ID: 28060833
[TBL] [Abstract][Full Text] [Related]
13. Reduced dynamin-related protein 1 protects against phosphorylated Tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.
Kandimalla R; Manczak M; Fry D; Suneetha Y; Sesaki H; Reddy PH
Hum Mol Genet; 2016 Nov; 25(22):4881-4897. PubMed ID: 28173111
[TBL] [Abstract][Full Text] [Related]
14. The role of mitochondrial dysfunction in Alzheimer's disease: A potential pathway to treatment.
Reiss AB; Ahmed S; Dayaramani C; Glass AD; Gomolin IH; Pinkhasov A; Stecker MM; Wisniewski T; De Leon J
Exp Gerontol; 2022 Jul; 164():111828. PubMed ID: 35508280
[TBL] [Abstract][Full Text] [Related]
15. PINK1 signalling rescues amyloid pathology and mitochondrial dysfunction in Alzheimer's disease.
Du F; Yu Q; Yan S; Hu G; Lue LF; Walker DG; Wu L; Yan SF; Tieu K; Yan SS
Brain; 2017 Dec; 140(12):3233-3251. PubMed ID: 29077793
[TBL] [Abstract][Full Text] [Related]
16. Cyclophilin D deficiency rescues axonal mitochondrial transport in Alzheimer's neurons.
Guo L; Du H; Yan S; Wu X; McKhann GM; Chen JX; Yan SS
PLoS One; 2013; 8(1):e54914. PubMed ID: 23382999
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress and altered mitochondrial protein expression in the absence of amyloid-β and tau pathology in iPSC-derived neurons from sporadic Alzheimer's disease patients.
Birnbaum JH; Wanner D; Gietl AF; Saake A; Kündig TM; Hock C; Nitsch RM; Tackenberg C
Stem Cell Res; 2018 Mar; 27():121-130. PubMed ID: 29414602
[TBL] [Abstract][Full Text] [Related]
18. Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer's disease.
Manczak M; Reddy PH
Hum Mol Genet; 2012 Dec; 21(23):5131-46. PubMed ID: 22926141
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial Dysfunction Triggers Synaptic Deficits via Activation of p38 MAP Kinase Signaling in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.
Yu Q; Du F; Douglas JT; Yu H; Yan SS; Yan SF
J Alzheimers Dis; 2017; 59(1):223-239. PubMed ID: 28598851
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
